Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Congenital Abnormalities × Rituximab × Clear all

Phase

Status

Sponsor Class

OTHER 3 OTHER_GOV 1 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, B-Cell, Marginal Zone 2 Sarcoma, Kaposi 1 Recurrence 1 Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphoma, AIDS-Related 1 Lymphoma 1 HIV Infections 1 Congenital Abnormalities 1 Castleman Disease 1

Interventions

zanubrutinib 1 Vincristine 1 Rituximab 1 Radiography, Panoramic 1 Prednisone 1 Epirubicin 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04668365 2025-04-25

Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma

Henan Cancer Hospital

Phase 2 Suspended

Congenital Abnormalities, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡